BI
BioAge Labs Inc.
BIOA · NASDAQ
$6.21 -0.80% (-$0.05)
1M -32.28%
Market Cap $233.8M
P/E Ratio -
Div. Yield -
ROE 28.99%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
50 /100
Fair P/B 0.62x
P/S 22.58x
EV/EBITDA N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 912.26%
Op. margin 1,026.28%
FCF margin 850.69%
Quality
0 /100
Poor ROE 28.99%
ROA 23.80%
Asset turnover 0.03x
Debt
69 /100
Low Current ratio 17.19x
Int. coverage -335.17x
Debt/Equity 0.01x
Stability
63 /100
Moderate EPS volatility 30.07%
Profitable years 0
Beta 0.94x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BIOA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kristen Fortney
Employees
61
Headquarters
Emeryville
Upcoming events
05 NOV
Earnings
Upcoming earnings report